HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased alloimmunisation and transfusion reaction reporting in patients with solid-phase panreactivity.

AbstractBACKGROUND:
Automated solid-phase antibody screening uses red blood cell (RBC) membranes immobilised on polystyrene test wells to detect RBC specific antibodies. Despite its time-saving and labour-saving benefits, this method produces a higher rate of nonspecific reactivity compared with manual screening. Solid-phase panreactivity (SPP) is characterised by panreactivity (ie, all test cells reacting) in solid-phase testing accompanied by a negative autocontrol and a lack of reactivity when the same screening cells are tested in tube. The mechanisms underlying SPP and its clinical significance remain unclear. The goals of this study were to describe the prevalence of SPP at our institution and determine the alloimmunisation and transfusion reaction rates within this population.
METHODS:
Data were collected on all patients undergoing type and screen testing over a 6-year period. Study patients undergoing subsequent transfusion were evaluated for reported transfusion reactions and development of new alloantibodies.
RESULTS:
Of the 76 051 patients studied, 0.7% demonstrated SPP of which 11% developed new alloantibodies. The transfusion reaction reporting rate among patients with SPP was 2%.
CONCLUSIONS:
Our data suggest that patients with SPP have higher rates of reported transfusion reactions and alloantibody development compared with those without SPP.
AuthorsAndrea M Olofson, Rachael M Chandler, Cynthia R Marx-Wood, Craig A Babcock, Nancy M Dunbar
JournalJournal of clinical pathology (J Clin Pathol) Vol. 70 Issue 11 Pg. 981-983 (Nov 2017) ISSN: 1472-4146 [Electronic] England
PMID28424235 (Publication Type: Journal Article)
CopyrightPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Chemical References
  • Isoantibodies
  • Isoantigens
Topics
  • Automation, Laboratory
  • Blood Grouping and Crossmatching (methods)
  • Erythrocyte Transfusion (adverse effects)
  • Erythrocytes (immunology)
  • Histocompatibility
  • Humans
  • Isoantibodies (blood)
  • Isoantigens (blood)
  • Predictive Value of Tests
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Factors
  • Transfusion Reaction (blood, etiology, immunology)
  • Workload

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: